Recursion Pharmaceuticals Inc.

01/07/2025 | Press release | Distributed by Public on 01/07/2025 08:15

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.